Menu
Το καλάθι σας

CFR- Code of Federal Regulations, Title 21, Food and Drugs, 200-299 2017

CFR- Code of Federal Regulations, Title 21, Food and Drugs, 200-299 2017
CFR- Code of Federal Regulations, Title 21, Food and Drugs, 200-299 2017
  • Συγγραφείς: USGPO
  • ISBN: 9780160938122
  • Εκδότης: CFR
  • Έτος Έκδοσης: 2017
95,40€
Χωρίς ΦΠΑ: 90,00€

Title 21 CFR, Parts 200-299, includes rules, regulations, procedures and administrative procedures associated with the Food and Drug Administration and Department of Health and Human Services (drugs), labeling, prescription drug advertising and marketing, guidelines for state licensing of wholesale prescription drug distributors, medication guides for prescription drugs, requirement for authorized dispensers and pharmacies to distribute a side effects statement, special requirements for specific human drugs, controlled drugs, and more...

Table of Contents:
Title 21 → Chapter I → Subchapter C
TITLE 21—Food and Drugs
CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED)
SUBCHAPTER C—DRUGS: GENERAL
200
200.5 to 200.200
GENERAL
201
201.1 to 201.328
LABELING
202
202.1
PRESCRIPTION DRUG ADVERTISING
203
203.1 to 203.70
PRESCRIPTION DRUG MARKETING
205
205.1 to 205.50
GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORS
206
206.1 to 206.10
IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE
207
207.1 to 207.81
REQUIREMENTS FOR FOREIGN AND DOMESTIC ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN DRUGS, INCLUDING DRUGS THAT ARE REGULATED UNDER A BIOLOGICS LICENSE APPLICATION, AND ANIMAL DRUGS, AND THE NATIONAL DRUG CODE
208
208.1 to 208.26
MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS
209
209.1 to 209.11
REQUIREMENT FOR AUTHORIZED DISPENSERS AND PHARMACIES TO DISTRIBUTE A SIDE EFFECTS STATEMENT
210
210.1 to 210.3
CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL
211
211.1 to 211.208
CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS
212
212.1 to 216.24
CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
225
225.1 to 225.202
CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS
226
226.1 to 226.115
CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES
250
250.11 to 250.250
SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS
290
290.1 to 290.10
CONTROLLED DRUGS
299
299.3 to 299.5
DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES

Γράψτε μια αξιολόγηση

Σημείωση: η HTML δεν επεξεργάζεται!
Κακή Καλή
Ετικέτες: CFR